Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Agbarya · SciRah

Researcher profile · Semantic Scholar

A. Agbarya

Share profile

A. Agbarya — researcher profile on SciRah

h-index: 18
Works: 118
Citations: 1,705

Most-cited papers

First line Immunotherapy for Non-Small Cell Lung Cancer
N. J. Nasser, M. Gorenberg, A. Agbarya
2020Pharmaceuticals404 citations Open access
Semantic Scholar
BRAF Mutant Lung Cancer: Programmed Death Ligand 1 Expression, Tumor Mutational Burden, Microsatellite Instability Status, and Response to Immune Check‐Point Inhibitors
E. Dudnik, N. Peled, H. Nechushtan, M. Wollner +15 more
2018Journal of Thoracic Oncology197 citations
Semantic Scholar
Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors
B. Waissengrin, A. Agbarya, Esraa Safadi, H. Padova +1 more
2021The Lancet Oncology164 citations Open access
Semantic Scholar
Potential Mechanisms of Cancer-Related Hypercoagulability
N. J. Nasser, J. Fox, A. Agbarya
2020Cancers83 citations Open access
Semantic Scholar
Impact of acupuncture and integrative therapies on chemotherapy‐induced peripheral neuropathy: A multicentered, randomized controlled trial
E. Ben-Arye, D. Hausner, N. Samuels, D. Gamus +7 more
2022Cancer47 citations
Semantic Scholar
Efficacy of the mRNA-Based BNT162b2 COVID-19 Vaccine in Patients with Solid Malignancies Treated with Anti-Neoplastic Drugs
A. Agbarya, Ina Sarel, T. Ziv-Baran, Sivan Agranat +13 more
2021Cancers42 citations Open access
Semantic Scholar
Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small-Cell Lung Cancer, Past, Present, and Future
Chun-Ho Szeto, W. Shalata, A. Yakobson, A. Agbarya
2021Journal of Clinical Medicine38 citations Open access
Semantic Scholar
Plasma Proteome–Based Test for First-Line Treatment Selection in Metastatic Non–Small Cell Lung Cancer
P. Christopoulos, M. Harel, K. McGregor, Y. Brody +33 more
2024JCO Precision Oncology28 citations Open access
Semantic Scholar
FGFR Fusions as an Acquired Resistance Mechanism Following Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) and a Suggested Novel Target in Advanced Non-Small Cell Lung Cancer (aNSCLC)
A. Raphael, E. Dudnik, D. Hershkovitz, Suyog Jain +8 more
2022Journal of Clinical Medicine27 citations Open access
Semantic Scholar
Overcoming Chemoresistance in Cancer: The Promise of Crizotinib
Sanaa Musa, Noor Amara, Adan Selawi, Jun-Biao Wang +3 more
2024Cancers22 citations Open access
Semantic Scholar
Real-World Journey of Unresectable Stage III NSCLC Patients: Current Dilemmas for Disease Staging and Treatment
A. Agbarya, W. Shalata, A. Addeo, A. Charpidou +8 more
2022Journal of Clinical Medicine22 citations Open access
Semantic Scholar
Clinical activity of brigatinib in ROS1-rearranged non-small cell lung cancer
E. Dudnik, A. Agbarya, R. Grinberg, A. Cyjon +3 more
2020Clinical and Translational Oncology20 citations
Semantic Scholar
Ovarian cancer ascites confers platinum chemoresistance to ovarian cancer cells
Yifat Koren Carmi, A. Agbarya, Hazem Khamaisi, R. Farah +4 more
2024Translational Oncology19 citations Open access
Semantic Scholar
Molecular Epidemiology and Treatment Patterns of Patients With EGFR Exon 20-Mutant NSCLC in the Precision Oncology Era: The European EXOTIC Registry
G. Mountzios, D. Planchard, G. Metro, D. Tsiouda +35 more
2022JTO Clinical and Research Reports18 citations Open access
Semantic Scholar
Attitudes Among Nurses Toward the Integration of Complementary Medicine Into Supportive Cancer Care.
E. Ben-Arye, Bella Shulman, Yael Eilon, Rachel Woitiz +13 more
2017Oncology Nursing Forum18 citations
Semantic Scholar
Perceptions of complementary medicine integration in supportive cancer care of Arabs and Jews in Israel: a cross-cultural study.
E. Ben-Arye, E. Schiff, M. Silbermann, A. Agbarya +1 more
2015Journal of Pain and Symptom Management18 citations Open access
Semantic Scholar
Maintaining consistent bladder filling during external beam radiotherapy for prostate cancer
N. J. Nasser, E. Fenig, J. Klein, A. Agbarya
2021Technical Innovations & Patient Support in Radiation Oncology17 citations Open access
Semantic Scholar
Efficacy of Pembrolizumab vs. Nivolumab Plus Ipilimumab in Metastatic NSCLC in Relation to PD-L1 and TMB Status
W. Shalata, Natalie Maimon Rabinovich, A. Agbarya, A. Yakobson +9 more
2024Cancers15 citations Open access
Semantic Scholar
Crizotinib in MET Exon 14-Mutated or MET-Amplified in Advanced Disease Non-Small Cell Lung Cancer: A Retrospective, Single Institution Experience
W. Shalata, A. Yakobson, Sarah Weissmann, E. Oscar +4 more
2022Oncology15 citations Open access
Semantic Scholar
Adjuvant Treatment with Tyrosine Kinase Inhibitors in Epidermal Growth Factor Receptor Mutated Non-Small-Cell Lung Carcinoma Patients, Past, Present and Future
W. Shalata, B. Jacob, A. Agbarya
2021Cancers15 citations Open access
Semantic Scholar
Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-ABL1T315I and BCR-ABL1T315I-E255K
A. Mian, I. Haberbosch, Hazem Khamaisie, A. Agbarya +9 more
2021Annals of Hematology15 citations Open access
Semantic Scholar
Efficacy and Safety of BRAF Inhibitors With or Without MEK Inhibitors in BRAF-Mutant Advanced Non-Small-Cell Lung Cancer: Findings From a Real-Life Cohort.
E. Dudnik, J. Bar, N. Peled, Elias Bshara +17 more
2019Clinical Lung Cancer15 citations
Semantic Scholar
Current and Emerging Therapeutic Strategies for Limited- and Extensive-Stage Small-Cell Lung Cancer
W. Shalata, Rashad Naamneh, Wenad Najjar, Mohnnad Asla +4 more
2025Medical Science14 citations Open access
Semantic Scholar
Biological insights from plasma proteomics of non-small cell lung cancer patients treated with immunotherapy
J. Bar, R. Leibowitz, Niels Reinmuth, A. Ammendola +23 more
2024bioRxiv14 citations Open access
Semantic Scholar
Anti-Inflammation Properties of Fruiting Bodies and Submerged Cultured Mycelia of Culinary-Medicinal Higher Basidiomycetes Mushrooms.
Rao-Chi Chien, Lan-Min Lin, Yuan-Hua Chang, Yu-Chieh Lin +7 more
2016International Journal of Medicinal Mushrooms13 citations
Semantic Scholar
Multi-Center Real-World Outcomes of Nivolumab Plus Ipilimumab and Chemotherapy in Patients with Metastatic Non-Small-Cell Lung Cancer
W. Shalata, A. Yakobson, Yulia Dudnik, F. Swaid +4 more
2023Biomedicines12 citations Open access
Semantic Scholar
Transanal Endoscopic Microsurgery After Neoadjuvant Chemoradiotherapy for Rectal Cancer
N. Issa, Alejandro Murninkas, H. Schmilovitz-Weiss, A. Agbarya +1 more
2015Journal of laparoendoscopic & advanced surgical techniques. Part A12 citations
Semantic Scholar
Acupuncture and integrative oncology for taxane-induced peripheral neuropathy: a randomized multicentered study
E. Ben-Arye, D. Gamus, N. Samuels, E. Schiff +7 more
2022International Journal of Gynecological Cancer11 citations Open access
Semantic Scholar
Treatment of Rare Mutations in Patients with Lung Cancer
T. Taha, R. Khoury, Ronen Brenner, H. Nasrallah +3 more
2021Biomedicines11 citations Open access
Semantic Scholar
Factors Predicting Type I Gastric Neuroendocrine Neoplasia Recurrence: A Single-Center Study
M. Sheikh-Ahmad, L. Saiegh, Anan Shalata, J. Bejar +10 more
2023Biomedicines10 citations Open access
Semantic Scholar
Markers of Toxicity and Response to Radiation Therapy in Patients With Prostate Cancer
N. J. Nasser, J. Klein, A. Agbarya
2020Advances in Radiation Oncology10 citations Open access
Semantic Scholar
Real-World Data on Osimertinib-Associated Cardiac Toxicity
A. Agbarya, Ari Raphael, Hadas Gantz Sorotsky, Y. Rottenberg +5 more
2025Journal of Clinical Medicine9 citations Open access
Semantic Scholar
Non-Small-Cell Lung Cancer Patients Harboring ROS1 Rearrangement: Real World Testing Practices, Characteristics and Treatment Patterns (ROS1REAL Study)
U. Janžič, Natalie Maimon Rabinovich, W. Shalata, W. Kian +9 more
2024Current Oncology9 citations Open access
Semantic Scholar
Real-World Experience in Treatment of Patients with Non-Small-Cell Lung Cancer with BRAF or cMET Exon 14 Skipping Mutations
U. Janžič, W. Shalata, Katarzyna Szymczak, R. Dziadziuszko +6 more
2023International Journal of Molecular Sciences9 citations Open access
Semantic Scholar
Unexpected and Rare Sites of Metastasis in Oncologic Patients
W. Shalata, Ashraf Abu Jama, A. Abu-Salman, Mitchell Golosky +6 more
2023Journal of Clinical Medicine8 citations Open access
Semantic Scholar
Long term follow-up of EGFR mutated NSCLC cases
G. Rennert, M. Gottfried, H. Rennert, F. Lejbkowicz +16 more
2020Translational Oncology8 citations Open access
Semantic Scholar
Efficacy of Tyrosine Kinase Inhibitors in ALK and EGFR-Mutated Non-Small Cell Lung Cancer with Brain Metastases
W. Shalata, Rashad Naamneh, Wenad Najjar, Mahmoud Abu Amna +9 more
2025Medical Science7 citations Open access
Semantic Scholar
Encephalitis Induced by Durvalumab During Treatment of Metastatic Small-Cell Lung Cancer: Illustrative Case and Review of the Literature.
Y. Shechtman, W. Shalata, R. Khoury, Ayed Mahajna +2 more
2021Journal of immunotherapy7 citations
Semantic Scholar
Real-World Clinical Outcomes of Neoadjuvant Platinum-Based Chemotherapy with Nivolumab in Non-Small Cell Lung Cancer
W. Shalata, S. Daher, Natali Maimon Rabinovitch, S. Shamai +11 more
2024Journal of Clinical Medicine6 citations Open access
Semantic Scholar
Is alectinib-induced elevation of creatine phosphokinase a predictive factor for response? Report of two cases and review of the literature.
W. Shalata, I. Massalha, A. Agbarya
2021Anti-Cancer Drugs6 citations
Semantic Scholar
Correlation Between Body Mass Index and Immunotherapy Response in Advanced NSCLC
W. Shalata, I. Gothelf, Yulia Dudnik, A. Y. Cohen +8 more
2025Cancers5 citations Open access
Semantic Scholar
Exploring the Impact of TP53 Mutation and Wild-Type Status on the Efficacy of Immunotherapy in Non-Small Cell Lung Cancer
A. Yakobson, Ronen Brenner, I. Gothelf, Natalie Maimon Rabinovich +6 more
2025International Journal of Molecular Sciences4 citations
Semantic Scholar
[Modeling integrative oncology care program for Arab patients in north Israel: towards quality of life improvement during chemotherapy].
E. Ben-Arye, Jamal Dagash, M. Silbermann, B. Saad +7 more
2015Harefuah4 citations
Semantic Scholar
Impact of Statin Use on Immunotherapy Outcomes and Efficacy in Non-Small Cell Lung Cancer Patients
A. Yakobson, A. Agbarya, Yulia Dudnik, I. Gothelf +8 more
2026International Journal of Molecular Sciences3 citations Open access
Semantic Scholar
The Correlation between Proliferative Immunohistochemical Markers and Papillary Thyroid Carcinoma Aggressiveness
M. Sheikh-Ahmad, Yara Shalata, J. Bejar, Hila Kreizman-Shefer +7 more
2023Medicina3 citations Open access
Semantic Scholar
The Impact of Comprehensive Genomic Profiling (CGP) on the Decision-Making Process in the Treatment of ALK-Rearranged Advanced Non-Small Cell Lung Cancer (aNSCLC) After Failure of 2nd/3rd-Generation ALK Tyrosine Kinase Inhibitors (TKIs)
A. Raphael, A. Onn, L. Holtzman, J. Dudnik +13 more
2022Frontiers in Oncology3 citations Open access
Semantic Scholar
Novel nanotech antioxidant cocktail prevents medical diagnostic procedures ionizing radiation effects
M. Gorenberg, A. Agbarya, D. Groshar, Ilya Volovik +2 more
2021Scientific Reports3 citations Open access
Semantic Scholar
Is Elevation of Alkaline Phosphatase a Predictive Factor of Response to Alectinib in NSCLC?
W. Shalata, A. Yakobson, R. Steckbeck, A. A. Jama +2 more
2021Current Oncology3 citations Open access
Semantic Scholar
Primary Papillary Serous Carcinoma of the Fallopian Tube Presenting as a Vaginal Mass: A Case Report and Review of the Literature
E. Kadour-Peero, L. Sagi-Dain, Gil Cohen, R. Korobochka +3 more
2018The American journal of case reports3 citations Open access
Semantic Scholar
Variant allele frequency as a predictor of treatment response to osimertinib in EGFR-mutated NSCLC
W. Shalata, B. Krayim, Asmah Miari, A. Agbarya +8 more
2026Frontiers in Molecular Biosciences2 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

W. Shalata×21
Invite
W. Shalata — researcher profile on SciRah
A. Yakobson×12
Invite
A. Yakobson — researcher profile on SciRah
Ashraf Abu Jama×7
Invite
Ashraf Abu Jama — researcher profile on SciRah
N. Peled×6
Invite
N. Peled — researcher profile on SciRah

×6

Invite

M. Moskovitz — researcher profile on SciRah

Invite

J. Bar — researcher profile on SciRah

Yulia Dudnik×6

Invite

Yulia Dudnik — researcher profile on SciRah

Invite

E. Dudnik — researcher profile on SciRah

H. Nechushtan×5

Invite

H. Nechushtan — researcher profile on SciRah

Invite

A. Onn — researcher profile on SciRah

Invite

E. Ben-Arye — researcher profile on SciRah

Invite

E. Schiff — researcher profile on SciRah